Distinct Mechanisms for Activation of the Opioid Receptor-Like 1 and κ-Opioid Receptors by Nociceptin and Dynorphin A
- 1 February 1999
- journal article
- Published by Elsevier in Molecular Pharmacology
- Vol. 55 (2) , 324-331
- https://doi.org/10.1124/mol.55.2.324
Abstract
To understand how two structurally analogous ligand-receptor systems, the nociceptin/opioid receptor-like 1 (ORL1) and dynorphin A/κ-opioid receptor 1 (KOR1) systems, achieve selectivity, receptor chimeras were generated and analyzed. Replacing discrete domains located between the N-terminus and top of the third transmembrane helix of the KOR1 by the homologous domains of the ORL1 receptor yields hybrid receptors, which, in comparison with the parent KOR1, display up to 300-fold increased affinity but low sensitivity toward nociceptin, and unaltered (high) affinity and sensitivity toward dynorphin A. These substitutions contribute elements for binding of nociceptin but do not suppress determinants necessary for binding and potency of dynorphin A. More importantly, further replacement in these chimeras of the second extracellular loop with that of the ORL1 receptor fully restores responsiveness to nociceptin without impairing responsiveness to dynorphin A. A bifunctional hybrid receptor has thus been identified that binds and responds to both nociceptin and dynorphin A as efficiently as the ORL1 receptor does to nociceptin and the KOR1 to dynorphin A. Together, these results suggest that distinct peptide activation mechanisms operate in the two receptor systems. In particular, the second extracellular receptor loop appears to be an absolute requirement for activation of the ORL1 receptor by nociceptin, but not for activation of the KOR1 by dynorphin A.Keywords
This publication has 38 references indexed in Scilit:
- ORL1, a novel member of the opioid receptor familyPublished by Wiley ,2001
- Different domains of the ORL1 and κ-opioid receptors are involved in recognition of nociceptin and dynorphin AFEBS Letters, 1998
- Nociceptin, an endogenous ligand for the ORL1 receptor, has novel hypotensive activity in the ratLife Sciences, 1997
- Diuretic and antinatriuretic responses produced by the endogenous opioid-like peptide, nociceptin (orphanin FQ)Life Sciences, 1996
- Replacement of Gln280 by His in TM6 of the human ORL1 receptor increases affinity but reduces intrinsic activity of opioidsFEBS Letters, 1996
- Structure-Activity Relationship Studies on the Novel Neuropeptide Orphanin FQPublished by Elsevier ,1996
- Orphanin FQ: Receptor binding and analog structure activity relationships in rat brainLife Sciences, 1996
- Extracellular Domains of the Bradykinin B2 Receptor Involved in Ligand Binding and Agonist Sensing Defined by Anti-peptide AntibodiesJournal of Biological Chemistry, 1996
- On the role of extracellular loops of opioid receptors in conferring ligand selectivityFEBS Letters, 1995
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973